Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
732,914
-
Shares change
-
-45,671
-
Total reported value, excl. options
-
$46,809,000
-
Value change
-
-$2,916,809
-
Number of sells
-
-8
-
Price
-
$63.86
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q1 2021
8 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q1 2021.
NOVOZYMES A S DKK 2.0 - COM has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 732,914 shares
.
Largest 8 shareholders include Hemenway Trust Co LLC (203,795 shares), SOMERVILLE KURT F (192,516 shares), Broderick Brian C (90,289 shares), PUZO MICHAEL J (83,635 shares), Kidder Stephen W (73,980 shares), Page Arthur B (34,045 shares), Notis-McConarty Edward (29,410 shares), and Dempze Nancy E (25,244 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.